Everidis introduces probiotic drops for kids
ST. LOUIS Everidis Health Sciences announced last week that it would begin distribution of BioGaia Probiotic Drops, a probiotic formulated for children. According to the company, the drop-form delivery system is the first in probiotics.
BioGala Drops contains L. reuteri—a double-blind, placebo-controlled study published online in the January edition of the Journal of Pediatrics found that L. reuteri improved gut function and feeding tolerance in formula-fed pre-term newborns.
Everidis already has distribution for its B-natal product via AmerisourceBergen; Cardinal; Dakota Drug; Harvard Drug; HD Smith; Kinray; McKesson; McQueary; Morris & Dickson; N.C. Mutual Drug; Smith Drug and Value Drug.
Review board rules against Osteo-Bi Flex ad claims
NEW YORK NBTY lost its appeal to The National Advertising Review Board, the board announced Monday, which recommended that the company discontinue use of “Double Strength” and “Triple Strength” descriptors on Osteo-Bi Flex product packaging and in other advertising unless those terms are qualified to indicate that they refer to the level of key ingredients in each individual caplet and does not imply greater product performance or efficacy.
The appeal originated from a monitoring case opened by the National Advertising Division of the Council of Better Business Bureaus. As part of NAD’s routine monitoring program, NAD requested substantiation for certain claims made by Rexall Sundown (owned by NBTY) for its Osteo Bi-Flex dietary supplement.
The panel also recommends that Rexall remove its claims that the Boswellia serrata extract in 5-LOXIN is 10 times more concentrated than typical Boswellia serrata extracts unless those claims are presented in a context that does not imply that the increased concentration results in increased product performance or efficacy.
Kuchta named Pharmavite evp, chief marketing officer
NORTHRIDGE, Calif. Pharmavite, manufacturer of Nature Made vitamins, minerals, herbs and dietary supplements and SoyJoy whole soy bars, announced today the promotion of Gary Kuchta to executive vice president and chief marketing officer, effective immediately.
“Gary’s extensive experience in building world-class consumer brands aligns perfectly with our growth objectives,” stated Connie Barry, Pharmavite president and chief executive officer. “His demonstrated thought-leadership, combined with his dedication and commitment to the continued growth and vitality of Pharmavite, will serve to solidify Pharmavite as an industry leader committed to offering high-quality, science-based products.”
In this new position, Kuchta will lead the company’s strategic marketing initiatives and will report to Barry.
He previously served as Pharmavite’s vice president of marketing—new products/innovation.
Prior to joining Pharmavite in 2006, Kuchta served as marketing director at Unilever, where he was responsible for the Dove, Suave, Sunsilk, Thermasilk and Finesse businesses in the U.S.
Kuchta holds a Masters of Business Administration from the University of Chicago and an undergraduate degree in Economics from the University of Notre Dame. He will continue to be based at Pharmavite’s headquarters in Northridge, California.